Endovascular cannulation with a microneedle for central retinal vein occlusion

JAMA Ophthalmology

Volumn 131, Issue 6, 2013, Pages 783-786

  Kadonosono, Kazuaki ^a   Yamane, Shin ^a   Arakawa, Akira ^a   Inoue, Maiko ^a   Yamakawa, Tadashi ^a   Uchio, Eiichi ^b   Yanagi, Yasuo ^c   Amano, Shiro ^c  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANNULATION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; ENDOVASCULAR CANNULATION; ENDOVASCULAR SURGERY; EQUIPMENT DESIGN; FEMALE; HUMAN; MALE; MICRONEEDLE; PRIORITY JOURNAL; RETINA MACULA EDEMA; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; FEMALE; FOVEA CENTRALIS; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; MINIATURIZATION; NEEDLES; PROSPECTIVE STUDIES; PUNCTURES; RECOVERY OF FUNCTION; RETINAL VEIN OCCLUSION; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84879050107     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.2585     Document Type: Article

References (17)

1. Orth DH, Patz A. Retinal branch vein occlusion. Surv Ophthalmol. 1978;22(6):357-376. (Pubitemid 8384633)
2. Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126(4):513-518. (Pubitemid 351549845)
3. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch Ophthalmol. 1996;114(10):1243-1247. (Pubitemid 26338856)
4. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108(12):2249-2257. (Pubitemid 33096938)
5. Tsilimbaris MK, Lit ES, D'Amico DJ. Retinal microvascular surgery: a feasibility study. Invest Ophthalmol Vis Sci. 2004;45(6):1963-1968. (Pubitemid 38868995)
6. Tameesh MK, Lakhanpal RR, Fujii GY, et al. Retinal vein cannulationwith prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. Am J Ophthalmol. 2004;138(5):829-839. (Pubitemid 39452931)
7. Bynoe LA, Hutchins RK, Lazarus HS, Friedberg MA. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons. Retina. 2005;25(5):625-632. (Pubitemid 41077268)
8. Feltgen N, Junker B, Agostini H, Hansen LL. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology. 2007;114(4):716-723.
9. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371-422.
10. Kadonosono K, Arakawa A, Yamane S, Uchio E, Yanagi Y. An experimental study of retinal endovascular surgery with a microfabricated needle. Invest Ophthalmol Vis Sci. 2011;52(8):5790-5793.
11. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol . 1997;115(4):486-491.
12. Hayreh SS. t-PA in CRVO. Ophthalmology. 2002;109(10):1758-1763.
13. Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N report. Ophthalmology. 1995;102(10):1434-1444.
14. Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology. 2011;118(10):2041- 2049.
15. Epstein DLJ, Algvere PV, von Wendt G, Seregard S, Kvanta A. Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study. Ophthalmology. 2012;119(6):1184-1189.
16. Boyer D, Heier J, Brown DM, et al. Vascular endothelial growth factor Trap-Eye formacular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. Ophthalmology. 2012;119(5):1024-1032.
17. Haller JA, Bandello F, Belfort R Jr, et al OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117(6):1134-1146.e3.